{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MBC", "Staphylococcus aureus DNA gyrase", "antimicrobial", "benzenesulfonamide", "docking", "nanoformulations", "nanoparticles", "quinazolinone"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32440116", "DateCompleted": {"Year": "2020", "Month": "07", "Day": "17"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S241433"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2020"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Novel <i>N</i>-(Substituted) Thioacetamide Quinazolinone Benzenesulfonamides as Antimicrobial Agents.", "Pagination": {"StartPage": "3161", "EndPage": "3180", "MedlinePgn": "3161-3180"}, "Abstract": {"AbstractText": ["With the rapid emergence of antibiotic resistance, efforts are being made to obtain new selective antimicrobial agents. Hybridization between quinazolinone and benzenesulfonamide can provide new antimicrobial candidates. Also, the use of nanoparticles can help boost drug efficacy and lower side effects.", "Novel quinazolinone-benzenesulfonamide derivatives <b>5-18</b> were synthesized and screened for their antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria, MRSA and yeast. The most potent compound <b>16</b> was conjugated with copper oxide nanoparticles 16-CuONPs by gamma irradiation (4.5 KGy). Characterization was performed using UV-Visible, TEM examination, XRD patterns and DLS. Moreover, compound <b>16</b> was used to synthesize two nanoformulations\ufeff: 16-CNPs by loading <b>16</b> in chitosan nanoparticles and the nanocomposites 16-CuONPs-CNPs. Characterization of these nanoformulations was performed using TEM and \ufeffzeta potential. Besides, the inhibitory profile against <i>Staphylococcus aureus</i> DNA gyrase was assayed. Cytotoxic evaluation of <b>16</b>, 16-CNPs and 16-CuONPs-CNPs on normal VERO cell line was carried out to determine its relative safety. Molecular docking of <b>16</b> was performed inside the active site of <i>S. aureus</i> DNA gyrase.", "Compound <b>16</b> was the most active in this series against all the tested strains and showed inhibition zones and MICs in the ranges of 25-36 mm and 0.31-5.0 \u00b5g/mL, respectively. The antimicrobial screening of the synthesized nanoformulations revealed that 16-CuONPs-CNPs displayed the most potent activity. The MBCs of <b>16</b> and the nanoformulations were measured and proved their bactericidal mode of action. The inhibitory profile against <i>S.\u00a0aureus</i> DNA gyrase showed IC<sub>50</sub> ranging from 10.57\u00a0to\u00a027.32 \u00b5M. Cytotoxic evaluation of <b>16</b>, 16-CNPs and 16-CuONPs-CNPs against normal VERO cell lines proved its relative safety (IC<sub>50</sub>= 927, 543 and 637 \u00b5g/mL, respectively). Molecular docking of <b>16</b> inside the active site of <i>S. aureus</i> DNA gyrase showed that it binds in the same manner as that of the co-crystallized ligand, ciprofloxacin.", "Compound <b>16</b> could be considered as a new antimicrobial lead candidate with enhanced activity upon nanoformulation."], "CopyrightInformation": "\u00a9 2020 Ghorab et al."}, "AuthorList": [{"Identifier": ["0000-0003-4250-0452"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11765, Egypt."}], "LastName": "Ghorab", "ForeName": "Mostafa M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Ali S", "Initials": "AS"}, {"Identifier": ["0000-0001-6562-9828"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11765, Egypt."}], "LastName": "Soliman", "ForeName": "Aiten M", "Initials": "AM"}, {"Identifier": ["0000-0003-3388-4634"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Botany and Microbiology Department, Faculty of Science (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Askar", "ForeName": "Ahmed A", "Initials": "AA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonamides"}, {"RegistryNumber": "0", "NameOfSubstance": "Topoisomerase II Inhibitors"}, {"RegistryNumber": "075T165X8M", "NameOfSubstance": "Thioacetamide"}, {"RegistryNumber": "789U1901C5", "NameOfSubstance": "Copper"}, {"RegistryNumber": "EC 5.99.1.3", "NameOfSubstance": "DNA Gyrase"}, {"RegistryNumber": "T8BEA5064F", "NameOfSubstance": "cuprous oxide"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bacteria"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Copper"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA Gyrase"}, {"QualifierName": [], "DescriptorName": "Gamma Rays"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "ultrastructure"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Quinazolinones"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Sulfonamides"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Thioacetamide"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Topoisomerase II Inhibitors"}, {"QualifierName": [], "DescriptorName": "Benzenesulfonamides"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zhang L, Peng XM, Damu GL, Geng RX, Zhou CH. Comprehensive review in current developments of imidazole\u2010based medicinal chemistry. Med Res Rev. 2014;34(2):340\u2013437. doi:10.1002/med.21290.", "ArticleIdList": ["10.1002/med.21290", "23740514"]}, {"Citation": "Peng X-M, Cai G-X, Zhou C-H. Recent developments in azole compounds as antibacterial and antifungal agents. Curr Top Med Chem. 2013;13(16):1963\u20132010. doi:10.2174/15680266113139990125", "ArticleIdList": ["10.2174/15680266113139990125", "23895097"]}, {"Citation": "Cui S-F, Addla D, Zhou C-H. Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, sars, and preliminary antibacterial mechanism. J Med Chem. 2016;59(10):4488\u20134510. doi:10.1021/acs.jmedchem.5b01678", "ArticleIdList": ["10.1021/acs.jmedchem.5b01678", "27115717"]}, {"Citation": "Zhang H-Z, Jeyakkumar P, Kumar KV, Zhou C-H. Synthesis of novel sulfonamide azoles via C\u2013N cleavage of sulfonamides by azole ring and relational antimicrobial study. New J Chem. 2015;39(7):5776\u20135796. doi:10.1039/C4NJ01932F", "ArticleIdList": ["10.1039/C4NJ01932F"]}, {"Citation": "Jang M-Y, De Jonghe S, Segers K, Ann\u00e9 J, Herdewijn P. Synthesis of novel 5-amino-thiazolo [4, 5-d] pyrimidines as E. coli and S. aureus SecA inhibitors. Bioorg Med Chem. 2011;19(1):702\u2013714. doi:10.1016/j.bmc.2010.10.027", "ArticleIdList": ["10.1016/j.bmc.2010.10.027", "21094610"]}, {"Citation": "Khatkar A, Nanda A, Kumar P, Narasimhan B. Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives. Arab J Chem. 2017;10:S3804\u2013S3815. doi:10.1016/j.arabjc.2014.05.018", "ArticleIdList": ["10.1016/j.arabjc.2014.05.018"]}, {"Citation": "Manikprabhu D, Lingappa K. Antibacterial activity of silver nanoparticles against methicillin-resistant Staphylococcus aureus synthesized using model Streptomyces sp. pigment by photo-irradiation method. J Pharm Res. 2013;6(2):255\u2013260. doi:10.1016/j.jopr.2013.01.022", "ArticleIdList": ["10.1016/j.jopr.2013.01.022"]}, {"Citation": "Dur\u00e1n N, Marcato PD, De Souza GI, Alves OL, Esposito E. Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J Biomed Nanotechnol. 2007;3(2):203\u2013208. doi:10.1166/jbn.2007.022", "ArticleIdList": ["10.1166/jbn.2007.022"]}, {"Citation": "Panagiotopoulos A, Zafiropoulos TF, Perlepes SP, et al. Molecular structure and magnetic properties of acetato-bridged lanthanide (III) dimers. Inorg Chem. 1995;34(19):4918\u20134920. doi:10.1021/ic00123a029", "ArticleIdList": ["10.1021/ic00123a029"]}, {"Citation": "El-Nawawy M, Farag R, Sabbah I, Abu-Yamin A. Synthesis, spectroscopic, thermal studies and biological activity of a new sulfamethoxazole schiff base and its copper complexes. Int J Pharm Sci Res. 2011;2(12):3143\u20133148."}, {"Citation": "Chevalier J, Mahamoud A, Baitiche M, et al. Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains. Int J Antimicrob Agents. 2010;36(2):164\u2013168. doi:10.1016/j.ijantimicag.2010.03.027", "ArticleIdList": ["10.1016/j.ijantimicag.2010.03.027", "20494558"]}, {"Citation": "Ghorab M, AbdelHamide S, ElHakim A. Synthesis of some new biologically active 2-phenyl-6-iodo-3-substituted-4 (3H) quinazolinones. Indian J Heterocy Chem. 1995;5(2):115\u2013120."}, {"Citation": "Mahamoud A, Chevalier J, Baitiche M, Adam E, Pages J-M. An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates. Microbiology. 2011;157(2):566\u2013571. doi:10.1099/mic.0.045716-0", "ArticleIdList": ["10.1099/mic.0.045716-0", "21071494"]}, {"Citation": "Devi KA, Sarangapani M. Synthesis and antimicrobial activity of some quinazolinones derivatives. Int J Drug Dev Res. 2012;4(3):324\u2013327."}, {"Citation": "Jafari E, Khajouei MR, Hassanzadeh F, Hakimelahi GH, Khodarahmi GA. Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities. Res Pharm Sci. 2016;11(1):1\u201314.", "ArticleIdList": ["PMC4794932", "27051427"]}, {"Citation": "Suresha G, Suhas R, Kapfo W, Gowda DC. Urea/thiourea derivatives of quinazolinone\u2013lysine conjugates: synthesis and structure\u2013activity relationships of a new series of antimicrobials. Eur J Med Chem. 2011;46(6):2530\u20132540. doi:10.1016/j.ejmech.2011.03.041", "ArticleIdList": ["10.1016/j.ejmech.2011.03.041", "21481990"]}, {"Citation": "Al-Omary FA, Hassan GS, El-Messery SM, Nagi MN, Habib E-SE, El-Subbagh HI. Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones. Eur J Med Chem. 2013;63:33\u201345. doi:10.1016/j.ejmech.2012.12.061", "ArticleIdList": ["10.1016/j.ejmech.2012.12.061", "23454532"]}, {"Citation": "Dinakaran M, Selvam P, DeClercq E, Sridhar SK. Synthesis, antiviral and cytotoxic activity of 6-bromo-2, 3-disubstituted-4 (3H)-quinazolinones. Biol Pharm Bull. 2003;26(9):1278\u20131282. doi:10.1248/bpb.26.1278", "ArticleIdList": ["10.1248/bpb.26.1278", "12951471"]}, {"Citation": "Lubenets V, Karpenko O, Ponomarenko M, Zahoriy G, Krychkovska A, Novikov V. Development of New Antimicrobial Compositions of Thiosulfonate Structure. 2013:119\u2013124."}, {"Citation": "Lubenets V, Vasylyuk S, Monka N, et al. Synthesis and antimicrobial properties of 4-acylaminobenzenethiosulfoacid S-esters. Saudi Pharm J. 2017;25(2):266\u2013274. doi:10.1016/j.jsps.2016.06.007", "ArticleIdList": ["10.1016/j.jsps.2016.06.007", "PMC5355547", "28344478"]}, {"Citation": "Elgadir MA, Uddin MS, Ferdosh S, Adam A, Chowdhury AJK, Sarker MZI. Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review. J Food Drug Anal. 2015;23(4):619\u2013629. doi:10.1016/j.jfda.2014.10.008", "ArticleIdList": ["10.1016/j.jfda.2014.10.008", "28911477"]}, {"Citation": "Park JH, Saravanakumar G, Kim K, Kwon IC. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. 2010;62(1):28\u201341. doi:10.1016/j.addr.2009.10.003", "ArticleIdList": ["10.1016/j.addr.2009.10.003", "19874862"]}, {"Citation": "Wu T, Wu C, Fu S, et al. Integration of lysozyme into chitosan nanoparticles for improving antibacterial activity. Carbohydr Polym. 2017;155:192\u2013200. doi:10.1016/j.carbpol.2016.08.076", "ArticleIdList": ["10.1016/j.carbpol.2016.08.076", "27702504"]}, {"Citation": "Mendoza G, Regiel-Futyra A, Andreu V, et al. Bactericidal effect of gold\u2013chitosan nanocomposites in coculture models of pathogenic bacteria and human macrophages. ACS Appl Mater Interfaces. 2017;9(21):17693\u201317701. doi:10.1021/acsami.6b15123", "ArticleIdList": ["10.1021/acsami.6b15123", "28225263"]}, {"Citation": "Usman MS, El Zowalaty ME, Shameli K, Zainuddin N, Salama M, Ibrahim NA. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine. 2013;8:4467\u20134479. doi:10.2147/IJN.S50837", "ArticleIdList": ["10.2147/IJN.S50837", "PMC3839804", "24293998"]}, {"Citation": "Salehi E, Daraei P, Shamsabadi AA. A review on chitosan-based adsorptive membranes. Carbohydr Polym. 2016;152:419\u2013432. doi:10.1016/j.carbpol.2016.07.033", "ArticleIdList": ["10.1016/j.carbpol.2016.07.033", "27516289"]}, {"Citation": "Ramyadevi J, Jeyasubramanian K, Marikani A, Rajakumar G, Rahuman AA. Synthesis and antimicrobial activity of copper nanoparticles. Mater Lett. 2012;71:114\u2013116. doi:10.1016/j.matlet.2011.12.055", "ArticleIdList": ["10.1016/j.matlet.2011.12.055"]}, {"Citation": "Khashan KS, Sulaiman GM, Abdulameer FA. Synthesis and antibacterial activity of CuO nanoparticles suspension induced by laser ablation in liquid. Arab J Sci Eng. 2016;41(1):301\u2013310. doi:10.1007/s13369-015-1733-7", "ArticleIdList": ["10.1007/s13369-015-1733-7"]}, {"Citation": "Emami-Karvani Z, Chehrazi P. Antibacterial activity of ZnO nanoparticle on gram-positive and gram-negative bacteria. Afr J Microbiol Res. 2011;5(12):1368\u20131373."}, {"Citation": "Gong -H-H, Addla D, Lv J-S, Zhou C-H. Heterocyclic naphthalimides as new skeleton structure of compounds with increasingly expanding relational medicinal applications. Curr Top Med Chem. 2016;16(28):3303\u20133364. doi:10.2174/1568026616666160506145943", "ArticleIdList": ["10.2174/1568026616666160506145943", "27150364"]}, {"Citation": "Ghorab MM, Alsaid MS, Soliman AM, Al-Mishari AA. Benzo [g] quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors. J Enzyme Inhib Med Chem. 2018;33(1):67\u201373. doi:10.1080/14756366.2017.1389922", "ArticleIdList": ["10.1080/14756366.2017.1389922", "PMC6010119", "29098904"]}, {"Citation": "Ghorab MM, Alsaid MS, Soliman AM, Ragab FA. VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo [g] quinazolin bearing benzenesulfonamide moiety. J Enzyme Inhib Med Chem. 2017;32(1):893\u2013907. doi:10.1080/14756366.2017.1334650", "ArticleIdList": ["10.1080/14756366.2017.1334650", "PMC6445170", "28661197"]}, {"Citation": "Alsaid MS, Al-Mishari AA, Soliman AM, Ragab FA, Ghorab MM. Discovery of Benzo [g] quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. Eur J Med Chem. 2017;141:84\u201391. doi:10.1016/j.ejmech.2017.09.061", "ArticleIdList": ["10.1016/j.ejmech.2017.09.061", "29028534"]}, {"Citation": "Ghorab MM, Alsaid MS, El-Gaby MS, Safwat NA, Elaasser MM, Soliman AM. Biological evaluation of some new N-(2, 6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents. Eur J Med Chem. 2016;124:299\u2013310. doi:10.1016/j.ejmech.2016.08.060", "ArticleIdList": ["10.1016/j.ejmech.2016.08.060", "27597407"]}, {"Citation": "Ghorab MM, Soliman AM, Alsaid MS, Askar AA. Synthesis, antimicrobial activity and docking study of some novel 4-(4, 4-dimethyl-2, 6-dioxocyclohexylidene) methylamino derivatives carrying biologically active sulfonamide moiety. Arab J Chem. 2020;13(1):545\u2013556. doi:10.1016/j.arabjc.2017.05.022", "ArticleIdList": ["10.1016/j.arabjc.2017.05.022"]}, {"Citation": "Murugavel S, Sundramoorthy S, Lakshmanan D, Subashini R, Kumar PP. Synthesis, crystal structure analysis, spectral (NMR, FT-IR, FT-Raman and UV\u2013Vis) investigations, molecular docking studies, antimicrobial studies and quantum chemical calculations of a novel 4-chloro-8-methoxyquinoline-2 (1H)-one: an effective antimicrobial agent and an inhibition of DNA gyrase and lanosterol-14\u03b1-demethylase enzymes. J Mol Struct. 2017;1131:51\u201372. doi:10.1016/j.molstruc.2016.11.035", "ArticleIdList": ["10.1016/j.molstruc.2016.11.035"]}, {"Citation": "Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1, 8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Chem. 1962;5(5):1063\u20131065. doi:10.1021/jm01240a021", "ArticleIdList": ["10.1021/jm01240a021", "14056431"]}, {"Citation": "Soliman AM, Ghorab MM. Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3, 4-dihydroquinazolin-2-yl) thio] acetamide derivatives as anticancer and radiosensitizing agents. Bioorg Chem. 2019;88:102956. doi:10.1016/j.bioorg.2019.102956", "ArticleIdList": ["10.1016/j.bioorg.2019.102956", "31054432"]}, {"Citation": "Cappuccino J, Sherman N. Microbiology, Laboratory Manual. India: Pearson Education, Inc New Delhi; 2004:282\u2013283."}, {"Citation": "Cooper K. The theory of antibiotic inhibition zones. Anal Microbiol. 1963;1\u201386."}, {"Citation": "Hassan AS, Askar AA, Nossier ES, Naglah AM, Moustafa GO, Al-Omar MA. Antibacterial evaluation, in silico characters and molecular docking of schiff bases derived from 5-aminopyrazoles. Molecules. 2019;24(17):3130. doi:10.3390/molecules24173130", "ArticleIdList": ["10.3390/molecules24173130", "PMC6749370", "31466322"]}, {"Citation": "Wikler M, Hindler J, Cockerill F, et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard,; CLSI Document M07-A8; ISBN: ISBN 1-56238-689-1. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2008."}, {"Citation": "Kawashima Y, Handa T, Kasai A, Takenaka H, Lin S, Ando Y. Novel method for the preparation of controlled\u2010release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate\u2013chitosan. J Pharm Sci. 1985;74(3):264\u2013268. doi:10.1002/jps.2600740308", "ArticleIdList": ["10.1002/jps.2600740308", "4009432"]}, {"Citation": "Dias FR, Novais JS, Devillart T, et al. Synthesis and antimicrobial evaluation of amino sugar-based naphthoquinones and isoquinoline-5, 8-diones and their halogenated compounds. Eur J Med Chem. 2018;156:1\u201312. doi:10.1016/j.ejmech.2018.06.050", "ArticleIdList": ["10.1016/j.ejmech.2018.06.050", "30006155"]}, {"Citation": "Alt S, Mitchenall LA, Maxwell A, Heide L. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. J Antimicrob Chemother. 2011;66(9):2061\u20132069. doi:10.1093/jac/dkr247", "ArticleIdList": ["10.1093/jac/dkr247", "21693461"]}, {"Citation": "Ghorab MM, El Ella DAA, Heiba HI, Soliman AM. Synthesis of certain new thiazole derivatives bearing a sulfonamide moiety with expected anticancer and radiosensitizing activities. J Mater Sci Eng A. 2011;1:684\u2013691."}, {"Citation": "Berne BJ, Pecora R. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. Courier Corporation; 2000."}, {"Citation": "El-Batal A, El-Sayed MH, Refaat BM, Askar AAZ. Marine streptomyces cyaneus strain alex-SK121 mediated eco-friendly synthesis of silver nanoparticles using gamma radiation. Br J Pharm Res. 2014;4(21):2525\u20132547. doi:10.9734/BJPR/2014/12224", "ArticleIdList": ["10.9734/BJPR/2014/12224"]}, {"Citation": "Etefagh R, Azhir E, Shahtahmasebi N. Synthesis of CuO nanoparticles and fabrication of nanostructural layer biosensors for detecting Aspergillus niger fungi. Sci Iran. 2013;20(3):1055\u20131058."}, {"Citation": "Clark J. Joint Committee on Powder Diffraction Standards (JCPDS). 1961. In Card."}, {"Citation": "Sun N, Li M, Cai S, et al. Antibacterial evaluation and mode of action study of BIMQ, a novel bacterial cell division inhibitor. Biochem Biophys Res Commun. 2019;514(4):1224\u20131230. doi:10.1016/j.bbrc.2019.05.086", "ArticleIdList": ["10.1016/j.bbrc.2019.05.086", "31109649"]}, {"Citation": "Keepers YP, Pizao PE, Peters GJ, van Ark-otte J, Winograd B, Pinedo HM. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer Clin Oncol. 1991;27(7):897\u2013900. doi:10.1016/0277-5379(91)90142-Z", "ArticleIdList": ["10.1016/0277-5379(91)90142-Z", "1834124"]}, {"Citation": "Bax BD, Chan PF, Eggleston DS, et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature. 2010;466(7309):935. doi:10.1038/nature09197", "ArticleIdList": ["10.1038/nature09197", "20686482"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "7"}, {"Year": "2020", "Month": "4", "Day": "3"}, {"Year": "2020", "Month": "5", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["32440116", "PMC7211327", "10.2147/IJN.S241433", "241433"]}}]}